AAAAAA

   
Results: 1-11 |
Results: 11
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid
Authors: Ahrens, T Sleeman, JP Schempp, CM Howells, N Hofmann, M Ponta, H Herrlich, P Simon, JC
Citation: T. Ahrens et al., Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid, ONCOGENE, 20(26), 2001, pp. 3399-3408
The NF2 tumor suppressor gene product, merlin, mediates contact inhibitionof growth through interactions with CD44
Authors: Morrison, H Sherman, LS Legg, J Banine, F Isacke, G Haipek, CA Gutmann, DH Ponta, H Herrlich, P
Citation: H. Morrison et al., The NF2 tumor suppressor gene product, merlin, mediates contact inhibitionof growth through interactions with CD44, GENE DEV, 15(8), 2001, pp. 968-980
Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway
Authors: Weg-Remers, S Ponta, H Herrlich, P Konig, H
Citation: S. Weg-remers et al., Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway, EMBO J, 20(15), 2001, pp. 4194-4203
CD44 expression and regulation during mammary gland development and function
Authors: Hebbard, L Steffen, A Zawadzki, V Fieber, C Howells, N Moll, J Ponta, H Hofmann, M Sleeman, J
Citation: L. Hebbard et al., CD44 expression and regulation during mammary gland development and function, J CELL SCI, 113(14), 2000, pp. 2619-2630
Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways
Authors: Matter, N Marx, M Weg-Remers, S Ponta, H Herrlich, P Konig, H
Citation: N. Matter et al., Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways, J BIOL CHEM, 275(45), 2000, pp. 35353-35360
The CD44 protein family: Roles in embryogenesis and tumor progression
Authors: Ponta, H Herrlich, P
Citation: H. Ponta et P. Herrlich, The CD44 protein family: Roles in embryogenesis and tumor progression, PEDIAT PATH, 18(4-5), 1999, pp. 381-393
Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen B
Authors: Sleeman, JP Kim, U LePendu, J Howells, N Coquerelle, T Ponta, H Herrlich, P
Citation: Jp. Sleeman et al., Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen B, ONCOGENE, 18(31), 1999, pp. 4485-4494
CD44 splice variants in draining lymph nodes precede allograft rejection of endocrine cells
Authors: Milde, KF Herrlich, P Ponta, H
Citation: Kf. Milde et al., CD44 splice variants in draining lymph nodes precede allograft rejection of endocrine cells, J MOL MED-J, 77(1), 1999, pp. 67-69
Characterisation of the murine gene encoding the intracellular hyaluronan receptor IHABP (RHAMM)
Authors: Fieber, C Plug, R Sleeman, J Dall, P Ponta, H Hofmann, M
Citation: C. Fieber et al., Characterisation of the murine gene encoding the intracellular hyaluronan receptor IHABP (RHAMM), GENE, 226(1), 1999, pp. 41-50
Prognostic value of CD44 variant expression in primary breast cancer
Authors: Foekens, JA Dall, P Klijn, JGM Skroch-Angel, P Claassen, CJC Look, MP Ponta, H Van Putten, WLJ Herrlich, P Henzen-Logmans, SC
Citation: Ja. Foekens et al., Prognostic value of CD44 variant expression in primary breast cancer, INT J CANC, 84(3), 1999, pp. 209-215
Hyaluronate-enhanced hematopoiesis: Two different receptors trigger the release of interleukin-1 beta and interlenkin-6 from bone marrow macrophages
Authors: Khaldoyanidi, S Moll, J Karakhanova, S Herrlich, P Ponta, H
Citation: S. Khaldoyanidi et al., Hyaluronate-enhanced hematopoiesis: Two different receptors trigger the release of interleukin-1 beta and interlenkin-6 from bone marrow macrophages, BLOOD, 94(3), 1999, pp. 940-949
Risultati: 1-11 |